Rupert Vessey

CIK 1677618 · EVP & President, Research · last filed 2026-03-02

Rupert Vessey is an EVP & President, Research who has filed 65 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for GENB, was dated Mar 2, 2026. Across all open-market trades the lifetime net is −$36.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.9M across reported positions. 34 SEC filings were submitted jointly with MYERS SQUIBB CO BRISTOL.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.87M

Companies

4

Total Filings

65

Lifetime Open-Market Net

-$36.95M

Filer Profile

Reported Address
471 W. SOUTH ST.
APT. 101
KALAMAZOO, MI 49007
Related Filers
MYERS SQUIBB CO BRISTOL — 34 joint filings, latest 2023-05-04
CELGENE CORP /DE/ — 23 joint filings, latest 2019-11-22
TECHNE CORP /MN/ — 10 joint filings, latest 2025-11-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GENB Director $15.72 $0 1 2026-03-02
TECH Director 10,987 $72.12 $792.4K $0 9 2025-11-03
BMY EVP & President, Research 48,406 $63.64 $3.08M -$35.57M 32 2023-05-04
CELGENE CORP /DE/ (CELGZ) Delisted PRES., RESEARCH AND EARLY DEV. 60,927 -$1.38M 22 2019-11-22

Recent Filings

65 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-02 GENB Grant (A) $0 EDGAR
2025-11-03 TECH Grant (A) +1,640 $0 EDGAR
2025-04-11 TECH Grant (A) $0 EDGAR
2024-10-28 TECH Grant (A) +1,462 $0 EDGAR
2023-10-30 TECH Grant (A) +1,625 $0 EDGAR
2023-05-04 BMY Sell (S) −50,385 -$3.38M EDGAR
2023-05-03 BMY Notice (144) −50,385 -$3.38M EDGAR
2023-03-14 BMY Mixed +36,763 -$2.53M EDGAR
2022-12-06 BMY Mixed +4,294 -$364.9K EDGAR
2022-11-09 BMY Mixed +6,694 -$553.9K EDGAR
Showing 110 of 65
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.